Sonnet BioTherapeutics, Inc. (SONN) is a biotechnology company with a focus on oncology. Its proprietary platform is targeted at biologic drugs of single or bispecific action. SONN has completed ...
Sonnet BioTherapeutics (NASDAQ:SONN) will effect a 1-for-22 reverse stock split of its outstanding common stock, the company said Thursday. The reverse stock split will be effective as of the ...
PRINCETON, N.J., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (“Sonnet” or the “Company”) (NASDAQ: SONN), a biopharmaceutical company developing innovative targeted ...
Plus, get the best of BroadwayWorld delivered to your inbox, and unlimited access to our editorial content across the globe. Watch Stewart's first two videos, of Sonnet 16 and Sonnet 1, here, as well ...
PRINCETON, N.J. - Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: NASDAQ: SONN), a biopharmaceutical company specializing in the development of targeted biologic drugs, announced it will implement a ...
Sonnet BioTherapeutics enacts 1-for-8 reverse stock splitThe change will also extend to the common stock issuable upon the exercise of outstanding warrants and stock options, with a corresponding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback